These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27278202)

  • 1. National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.
    Minami CA; Wayne JD; Yang AD; Martini MC; Gerami P; Chandra S; Kuzel TM; Winchester DP; Palis BE; Bilimoria KY
    Ann Surg Oncol; 2016 Oct; 23(11):3548-3557. PubMed ID: 27278202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.
    Kinnier CV; Paruch JL; Dahlke AR; Wayne JD; Benson AB; Winchester DP; Bilimoria KY
    Ann Surg; 2016 Feb; 263(2):392-8. PubMed ID: 26488806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Risk Factors in Lymphatic Surgeries for Melanoma: A National Surgical Quality Improvement Program Review.
    Ascha M; Ascha MS; Gastman B
    Ann Plast Surg; 2017 Nov; 79(5):509-515. PubMed ID: 28650410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
    Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
    Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
    Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
    J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
    Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
    Scott JD; McKinley BP; Bishop A; Trocha SD
    Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity.
    Ul-Mulk J; Hölmich LR
    Dan Med J; 2012 Jun; 59(6):A4441. PubMed ID: 22677239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections.
    Shulman LN; Browner AE; Palis BE; Mallin K; Kakade S; Carp N; McCabe R; Winchester D; Wong SL; McKellar DP
    Ann Surg Oncol; 2019 Jun; 26(6):1613-1621. PubMed ID: 30927195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
    Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
    Wasif N; Gray RJ; Bagaria SP; Pockaj BA
    Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
    Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
    Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
    de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
    Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.
    Picon AI; Coit DG; Shaha AR; Brady MS; Boyle JO; Singh BB; Wong RJ; Busam KJ; Shah JP; Kraus DH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9001-9009. PubMed ID: 16715435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.